Elizabeth Hazel

Dr. Elizabeth Hazel is an Associate Investigator at the McGill University Health Centre Research Institute (RI-MUHC), affiliated with the Infectious Diseases and Immunity in Global Health Program. She holds an MD and conducts research at the Montreal General Hospital site. Her work bridges clinical rheumatology, vaccinology, and autoimmune disease management.

Her research focuses on:

• Vaccine hesitancy and safety in immunosuppressed populations (COVID-19/influenza)
• Transition care models for young adults with juvenile idiopathic arthritis
• Ehlers-Danlos syndrome biomechanics and functional assessments
• Workplace challenges for rheumatic disease patients

Analysis of her recent publications reveals strong emphasis on improving clinical outcomes through vaccine efficacy studies, patient transition frameworks, and quantitative assessments of physical function in connective tissue disorders. Her work consistently addresses knowledge gaps in managing autoimmune conditions across life stages.